adverse cytogenetics

Related by string. * ADVERSE . Adverse : FDA MedWatch Adverse Event . adverse determinations . adverse effects . adverse impacts . treatment emergent adverse . adverse inference / Cytogenetics . Cytogenetic : additional cytogenetic abnormalities . deletion 5q cytogenetic abnormality . include cytogenetics fluorescence . unfavorable cytogenetics . cytogenetics . complete cytogenetic response * *

Related by context. Frequent words. (Click for all words.) 66 tumor lysis syndrome 66 therapeutic regimens 64 T2DM 64 mycophenolate mofetil 64 azacitidine 64 interferon therapy 64 chlorambucil 63 heavily pretreated 63 malignant pleural mesothelioma 63 mRCC 63 allogeneic stem cell 63 haematological 63 HSCT 63 concomitant medications 63 breast carcinoma 63 renal insufficiency 63 liver transplant recipients 62 nilotinib 62 pheochromocytoma 62 pancreatic insufficiency 62 NYHA Class II 62 DMARD 62 hyperkalemia 62 Lenalidomide 62 thromboprophylaxis 62 disease modifying antirheumatic 62 myelodysplastic syndrome MDS 62 cytotoxic chemotherapy 62 juvenile idiopathic arthritis 62 comorbid conditions 61 dasatinib 61 immunosuppressive agents 61 fludarabine 61 hyperparathyroidism 61 ischemic cardiomyopathy 61 calcineurin inhibitors 61 Dasatinib 61 severe renal impairment 61 renal toxicity 61 thrombophilia 61 multiple myeloma MM 61 Torisel 60 antihypertensive agents 60 hematologic 60 TKIs 60 virologic failure 60 % CI #.#-#.# [007] 60 Natalizumab 60 prospectively defined 60 peginterferon 60 KRAS mutations 60 surrogate endpoint 60 TNF inhibitors 60 arterial thrombosis 60 surrogate markers 60 patients evaluable 60 DOXIL 60 carcinoid tumors 60 familial hypercholesterolemia 60 angiotensin converting enzyme inhibitors 60 androgen deprivation 60 lung fibrosis 60 immunosuppressed 60 biochemical recurrence 60 indolent NHL 60 antihypertensive therapy 60 fibrinolysis 60 platelet reactivity 60 nonobese 60 metastatic bone 60 cardiac dysfunction 60 superficial bladder cancer 60 metastatic renal cell carcinoma 60 vandetanib 60 Fibrillex TM 60 adjuvant chemotherapy 59 null responders 59 palliation 59 hypercalcemia 59 elevated LDL cholesterol 59 carcinoid 59 Fludara 59 tirofiban 59 irbesartan 59 olmesartan 59 EGFR inhibitors 59 lymphopenia 59 comorbidities 59 coronary intervention 59 renal impairment 59 alteplase 59 evaluable 59 cerebrovascular events 59 tumor recurrence 59 eplerenone 59 acute GVHD 59 cytogenetic response 59 sensory neuropathy 59 pneumonectomy 59 chemoradiotherapy 59 acute coronary syndromes ACS

Back to home page